biotech
MAS review group incentives could pull in regional biotech, fintech players: observers
High-growth companies in the technology, healthcare and sustainability-linked industries are potential entrants, tooMARKET watchers believe tax incentives proposed by the Monetary Authority of Singapore’s (MAS) equities market review group...
GSK to buy US cancer biotech IDRx for up to US$1.15 billion
GSK agreed to buy US biotech IDRx for as much as US$1.15 billion to gain new cancer medicines. The UK drugmaker will pay US$1 billion upfront for IDRx, whose lead...
Johnson & Johnson is in talks to buy US$10 billion biotech Intra-Cellular
JOHNSON & Johnson (J&J) is in talks to acquire Intra-Cellular Therapies, a biopharmaceutical company focused on treatments for central nervous system disorders, sources familiar with the matter said. A...
Big Pharma’s bet on China biotech is a rare trade bright spot
AT A time when geopolitical tensions are hitting industries from semiconductors to electric vehicles, pharmaceutical dealmaking has become a rare bright spot for collaboration between China and the West....
After TikTok, China biotech next to face wrath of US congress
CHINA hawks in the US House are working to overcome a last-ditch lobbying effort and pass legislation as early as on Monday (Sep 9) night that would blacklist Chinese...
US House passes bill to blacklist some China biotech firms
CHINA hawks in the US House overcame a last-ditch lobbying effort and passed legislation on Monday (Sep 9) night that would blacklist Chinese biotech companies and their US subsidiaries.The...
US House passes bill to blacklist some China biotech firms
CHINA hawks in the US House overcame a last-ditch lobbying effort and passed legislation on Monday (Sep 9) night that would blacklist Chinese biotech companies and their US subsidiaries.The...
Temasek-backed biotech Oxford Nanopore wants to make genetics tech accessible to startups
The London-listed company is working with Singapore to catalogue 10,000 genes, which can help to pinpoint how genetic factors influence responses to medicationWHEN the Covid-19 pandemic broke out, countries...
Hilleman-Bharat Biotech partnership brings new oral cholera vaccine to market
Hillchol utilises a single, genetically engineered inactivated strain that significantly reduces production costsHILLEMAN Laboratories and Indian drugmaker Bharat Biotech have announced the launch of oral cholera vaccine Hillchol, which...
- « Previous
- 1
- 2
- 3
- Next »